The Yale combination chemotherapy program for advanced Hodgkin's disease. A preliminary report.
D000293:Adolescent; D000328:Adult; D000963:Antimetabolites / Q000008:administration & dosage*; D001565:Benzoates / Q000008:administration & dosage; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage*; D011241:Prednisone / Q000008:administration & dosage*; D012577:Schools, Medical; D014747:Vinblastine / Q000008:administration & dosage*; D014750:Vincristine / Q000008:administration & dosage*
D000963:Antimetabolites; D001565:Benzoates; D009588:Nitrogen Mustard Compounds; D014750:Vincristine; D014747:Vinblastine; D011241:Prednisone